While data on liver or cardiac events (e.g., liver fibrosis/cirrhosis, portal hypertension, ischemic heart disease) are documented as part of real‐world patient follow‐up, these outcomes are infrequent, thus limiting extrapolation of ALT or AST data to clinical outcomes. The gene discussed is GPT; the disease is Cirrhosis.